5-(pyridin-4-ylmethyl)thiazol-2-amine

ID: ALA4854093

Cas Number: 1498119-01-9

PubChem CID: 65581130

Max Phase: Preclinical

Molecular Formula: C9H9N3S

Molecular Weight: 191.26

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncc(Cc2ccncc2)s1

Standard InChI:  InChI=1S/C9H9N3S/c10-9-12-6-8(13-9)5-7-1-3-11-4-2-7/h1-4,6H,5H2,(H2,10,12)

Standard InChI Key:  VPGXVWDRMUIBTM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
   21.3047  -26.5505    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.1260  -26.5505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3845  -25.7697    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7174  -25.2834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0546  -25.7697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2731  -25.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6620  -26.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6097  -27.2163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8814  -25.8099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2747  -26.3604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4447  -27.1647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2309  -27.4157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8384  -26.8635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  5  6  1  0
  6  7  1  0
  2  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  7  1  0
M  END

Alternative Forms

Associated Targets(Human)

KCNMA1 Tclin Calcium-activated potassium channel subunit alpha-1 (435 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 191.26Molecular Weight (Monoisotopic): 191.0517AlogP: 1.71#Rotatable Bonds: 2
Polar Surface Area: 51.80Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.51CX LogP: 1.49CX LogD: 1.49
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.79Np Likeness Score: -1.39

References

1. Qi XL, Jo H, Wang XY, Ji TT, Lin HX, Park CS, Cui YM..  (2021)  Synthesis and BK channel-opening activity of 2-amino-1,3-thiazole derivatives.,  43  [PMID:33964448] [10.1016/j.bmcl.2021.128083]
2. Valverde, M A MA and 8 more authors.  1999-09-17  Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit.  [PMID:10489376]
3. Gribkoff, V K VK and 29 more authors.  2001-04  Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.  [PMID:11283675]

Source